Beyond Air Stock Price | XAIR Stock Quote, News, and History

Feb. 04 2021 Mar. 05 2021

Download Reset

Loading..
DateOpenCloseDaily HighDaily Low

Price change over selected period: 0% 0

Total Analysts: 4

Buy Ratings: 4 Neutral Ratings: 0 Sell Ratings: 0

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 3.50 Median: 9.63 Highest: 15.00

All
  • All
  • Buy
  • Hold
  • Sell
  • Yearly
  • Quarterly
 2024202520262027
Revenue---65
Dividend----
Dividend Yield (in %)----
EPS----0.50
P/E Ratio-0.29-0.49-0.64-1.17
EBIT--49-40-22
EBITDA----
Net Profit--50-41-24
Net Profit Adjusted----
Pre-Tax Profit--51-42-25
Net Profit (Adjusted)--61-61-44
EPS (Non-GAAP) ex. SOE----
EPS (GAAP)--1.20-0.89-0.90
Gross Income-11645
Cash Flow from Investing----
Cash Flow from Operations----
Cash Flow from Financing----
Cash Flow per Share----
Free Cash Flow----
Free Cash Flow per Share----
Book Value per Share----
Net Debt----
Research & Development Exp.-191920
Capital Expenditure----
Selling, General & Admin. Exp.-354361
Shareholder’s Equity----
Total Assets----
 Previous Quarter
ending 06/30/24
Current Quarter
ending 09/30/24
Next Quarter
ending 12/31/24
Current Year
ending 03/31/27
Next Year
Earnings Estimates
No. of Analysts---3-
Average Estimate----0.500 USD-
Year Ago-----
Publish Date-----
Revenue Estimates
No. of Analysts---3-
Average Estimate---65 USD-
Year Ago-----
Publish Date-----

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

DateNameDividend*yieldCurrency
2024Beyond Air0.000.00USD
2023Beyond Air0.000.00USD
2022Beyond Air0.000.00USD
2021Beyond Air0.000.00USD
2020Beyond Air0.000.00USD
2019Beyond Air0.000.00USD
2017Beyond Air0.000.00USD

*Yield of the Respective Date

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Risk
  • Low
  • Medium
  • High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’sbalance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of creditrisk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes intoaccount day-to-day movements in market value compared to a company’s liability structure.

Ownerin %
Freefloat81.14
AIGH Capital Management LLC8.09
Charles Mosseri Marlio7.02
Robert F. Carey6.49
Steven A. Lisi3.71
Tontine Associates LLC3.18
Kingdon Capital Management LLC2.96
Vanguard Group, Inc. (Subfiler)2.93
RTW Investments LP2.62
Adar1 Capital Management LLC2.62
BlackRock Fund Advisors1.99
Rosalind Advisors, Inc.1.97
Vanguard Total Stock Market ETF1.92
BlackRock Institutional Trust Co. NA1.68
Geode Capital Management LLC1.35

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xoqq2nk6DAcMTAoqlmq6SksKw%3D